Class II

Drug Recall: Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packagin

Legacy Pharmaceutical Packaging LLC · December 11, 2023

Reason for Recall

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Product Description

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

Distribution

CA and AR

States Affected

AR, CA

Quantity Affected

161,664 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0205-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.